Novartis AG ADR sell Barclays PLC
Start price
22.02.25
/
50%
€103.50
Target price
22.02.26
-
Performance (%)
18.23%
Price
30.12.25
€118.50
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 18.23%. Dividends of €3.87 are taken into consideration when calculating the performance. This prediction currently runs until 22.02.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novartis AG ADR | 0.000% | 0.000% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Barclays_PLC for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for NVS provided by MarketBeat